Remunix is developing novel therapeutics for the treatment of autoimmune diseases. Our approach is based on new insights into the fundamental biology of immune cell activation and checkpoints. We are pioneering a new class of antibody-based drugs that will safely and selectively attenuate the autoimmune response.